Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Prostate Cancer Diagnostics
The 2025-2030 World Outlook for Prostate Cancer Diagnostics This study covers the world outlook for prostate cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics This study covers the world outlook for prostate cancer nuclear medicine diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics This study covers the world outlook for uterine cancer treatments and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Uterine Sarcoma Therapeutics and Diagnostics
The 2025-2030 World Outlook for Uterine Sarcoma Therapeutics and Diagnostics This study covers the world outlook for uterine sarcoma therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies
The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies This study covers the world outlook for breast cancer liquid biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Therapeutics
The 2025-2030 World Outlook for Breast Cancer Therapeutics This study covers the world outlook for breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products This study covers the world outlook for breast cancer diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics
The 2025-2030 World Outlook for Breast Cancer Diagnostics This study covers the world outlook for breast cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Screenings
The 2025-2030 World Outlook for Breast Cancer Screenings This study covers the world outlook for breast cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Metastatic Bone Disease Medications
The 2025-2030 World Outlook for Metastatic Bone Disease Medications This study covers the world outlook for metastatic bone disease medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Germcitabine HCI
The 2025-2030 World Outlook for Germcitabine HCI This study covers the world outlook for germcitabine HCI across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics This study covers the world outlook for uterine cancer therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries This study covers the world outlook for thoracotomy lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Blood Cancers
The 2025-2030 World Outlook for Blood Cancers This study covers the world outlook for blood cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Drugs
The 2025-2030 World Outlook for Gastric Cancer Drugs This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Inorganic Capsule and Vascular Material Systems
The 2025-2030 World Outlook for Inorganic Capsule and Vascular Material Systems This study covers the world outlook for inorganic capsule and vascular material systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma
The 2025-2030 World Outlook for Multiple Myeloma This study covers the world outlook for multiple myeloma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
Research Assistance
